165 related articles for article (PubMed ID: 3015709)
21. Immunohistochemistry of pancreatic islet cell tumors in the ferret (Mustela putorius furo).
Andrews GA; Myers NC; Chard-Bergstrom C
Vet Pathol; 1997 Sep; 34(5):387-93. PubMed ID: 9381649
[TBL] [Abstract][Full Text] [Related]
22. Immunoreactivity of neuron-specific enolase (NSE) in human pancreas in health and type 1 diabetes mellitus.
Proshchina AE; Savelyev SV; Barabanov VM; Krivova YS
Bull Exp Biol Med; 2010 Nov; 149(6):763-7. PubMed ID: 21165441
[TBL] [Abstract][Full Text] [Related]
23. DU-PAN-2 levels in serum and pancreatic ductal fluids of patients with benign and malignant pancreatic disease.
Mahvi DM; Seigler HF; Meyers WC; Kalthoff H; Schmiegel WH; Metzgar RS
Pancreas; 1988; 3(4):488-93. PubMed ID: 3174610
[TBL] [Abstract][Full Text] [Related]
24. The distribution and localization of the monoclonal antibody-defined antigen 19-9 (CA19-9) in chronic pancreatitis and pancreatic carcinoma. An immunohistochemical study.
Makovitzky J
Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 51(6):535-44. PubMed ID: 2878526
[TBL] [Abstract][Full Text] [Related]
25. Abnormal differentiation of islet cells in pancreatic cancer.
Pour PM; Schmied BM; Ulrich AB; Friess H; Andrén-Sandberg A; Büchler MW
Pancreatology; 2001; 1(2):110-6. PubMed ID: 12120188
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical staining of pancreatic cancer with CA19-9, KM01, unabsorbed CEA, and absorbed CEA. A comparison with normal pancreas and chronic pancreatitis.
Shimizu M; Saitoh Y; Ohyanagi H; Itoh H
Arch Pathol Lab Med; 1990 Feb; 114(2):195-200. PubMed ID: 1689141
[TBL] [Abstract][Full Text] [Related]
27. Are biochemical markers of neuroendocrine tumors coreleased with insulin following local calcium stimulation in patients with insulinomas?
Wiesli P; Uthoff H; Perren A; Pfammatter T; Zwimpfer C; Seiler H; Kindhauser R; Spinas GA; Schmid C
Pancreas; 2011 Oct; 40(7):995-9. PubMed ID: 21705951
[TBL] [Abstract][Full Text] [Related]
28. [Clinical and prognostic significance of tumor markers cytokeratin 19 fragment, carcinoembryonic antigen, and neuron-specific enolase in lung cancer].
Zemaitis M; Sakalauskas R; Malakauskas K; Muley T; Fischer JR; Lahm H
Medicina (Kaunas); 2005; 41(7):566-76. PubMed ID: 16062024
[TBL] [Abstract][Full Text] [Related]
29. [The contribution of CA 19-9 in the differential diagnosis between chronic pancreatitis and cancer of the pancreas].
Van Gossum M; Delanghe A; Gerard M; Delcourt A; Deltenre M
Acta Gastroenterol Belg; 1987; 50(1):91-4. PubMed ID: 3480672
[No Abstract] [Full Text] [Related]
30. Pancreatic carcinoma versus chronic pancreatitis: computer-aided diagnosis.
Ruszkowski J; Milewski J
Mater Med Pol; 1987; 19(3):153-7. PubMed ID: 2836669
[No Abstract] [Full Text] [Related]
31. Serum neuron-specific enolase in diagnosis and follow-up of gastrointestinal neuroendocrine tumors.
D'Alessandro M; Mariani P; Lomanto D; Carlei F; Lezoche E; Speranza V
Tumour Biol; 1992; 13(5-6):352-7. PubMed ID: 1290031
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibody HISL-19 as an immunocytochemical probe for neuroendocrine differentiation. Its application in diagnostic pathology.
Krisch K; Buxbaum P; Horvat G; Krisch I; Neuhold N; Ulrich W; Srikanta S
Am J Pathol; 1986 Apr; 123(1):100-8. PubMed ID: 3515956
[TBL] [Abstract][Full Text] [Related]
33. [Determination of various tumor markers, with special reference to neuron-specific enolase in lung cancer].
Yano H; Hino M; Nishiwaki Y; Kodama T; Hayashibe A; Kudo H; Inoue Y; Nishiyama Y; Sone Y; Oshima T
Gan To Kagaku Ryoho; 1987 Jan; 14(1):77-83. PubMed ID: 3026257
[TBL] [Abstract][Full Text] [Related]
34. MR imaging of the pancreas: a practical approach.
Ly JN; Miller FH
Radiol Clin North Am; 2002 Dec; 40(6):1289-306. PubMed ID: 12479712
[TBL] [Abstract][Full Text] [Related]
35. Scintiphotos of the pancreas: analysis of 134 studies.
Hatchette JB; Shuler SE; Murison PJ
J Nucl Med; 1972 Jan; 13(1):51-7. PubMed ID: 4332572
[No Abstract] [Full Text] [Related]
36. Experience with radioisotope scanning of the pancreas.
Steven LW; Andrews JT; Arkles LB
Med J Aust; 1972 Oct; 2(16):867-73. PubMed ID: 4345929
[No Abstract] [Full Text] [Related]
37. Tumor markers in uremia: carcinoembryonic antigen, neuron-specific enolase, carbohydrate antigen CA-50 and alpha-fetoprotein.
DeSanto NG; Veneroso S; Capodicasa G; Crisci A; Giordano C
Am J Nephrol; 1986; 6(6):458-63. PubMed ID: 2436478
[TBL] [Abstract][Full Text] [Related]
38. Significance of adenocarcinoma-associated antigen YH206 levels in the pancreatic juice.
Imai K; Ban T; Endo T; Hinoda Y; Sugiyama T; Hirane T; Yabana T; Hirata K; Wada T; Yachi A
Gastroenterol Jpn; 1990 Feb; 25(1):112-6. PubMed ID: 2407594
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical detection of chromogranin and neuron-specific enolase in pancreatic endocrine neoplasms.
Lloyd RV; Mervak T; Schmidt K; Warner TF; Wilson BS
Am J Surg Pathol; 1984 Aug; 8(8):607-14. PubMed ID: 6205601
[TBL] [Abstract][Full Text] [Related]
40. Insulinoma in a patient with annular pancreas.
Schlinkert RT; Burns B; Argueta R; Whitaker MD; Danielson KS; Trejos FA
Mayo Clin Proc; 1990 Apr; 65(4):518-20. PubMed ID: 2159094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
